Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
Rotterdam score predicts early mortality in Budd-Chiari syndrome, and surgical shunting prolongs transplant-free survival
Alimentary Pharmacology and Therapeutics, 10/23/09
Bain VG et al. – Rotterdam score is the best discrimination index for 3–month mortality in Budd–Chiari syndrome and should be used preferentially to determine treatment urgency. Surgical shunts constitute an important therapeutic modality that may help save liver grafts and prolong transplantation–free survival in a selected group of patients with Budd–Chiari syndrome.
Today in Hepatobiliary/Pancreas...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Pancreaticojejunostomy with a Low Rate of Anastomotic Failure-Related Complications
Journal of the American College of Surgeons, 10/30/09
Day case laparoscopic cholecystectomy is feasible
Irish Journal of Medical Science, 11/02/09
Surgical management of hepatocellular carcinoma: Is the jury still out
Surgical Oncology, 11/05/09
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Outcomes After Liver Transplant in Patients Aged 70 Years or Older Compared With Those Younger Than 60 Years
Mayo Clinic Proceedings, 11/02/09
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome
Hepatology, 11/04/09
Hepatocellular carcinoma and evidence-based surgery
World Journal of Gastroenterology, 11/18/09
Sponsor
Article Search
Sponsor


See Latest Articles


